 | • レポートコード：B-GIR08C4455 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ピルフェニドンの世界市場について調べ、まとめました。種類別セグメントは、タブレット、カプセル、その他等、用途別セグメントは、軽度特発性肺線維症、中等度特発性肺線維症、その他等に区分しました。ピルフェニドンの世界市場概観、企業動向、企業別ピルフェニドンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ピルフェニドンの市場概観 ・ピルフェニドンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ピルフェニドンの企業別販売動向、市場シェア、市場集中度、競争動向 ・ピルフェニドンの世界市場規模 ・ピルフェニドンの北米市場分析（アメリカ、カナダ、メキシコ等） ・ピルフェニドンのアメリカ市場規模推移 ・ピルフェニドンのカナダ市場規模推移 ・ピルフェニドンのメキシコ市場規模推移 ・ピルフェニドンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ピルフェニドンのドイツ市場規模推移 ・ピルフェニドンのイギリス市場規模推移 ・ピルフェニドンのロシア市場規模推移 ・ピルフェニドンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ピルフェニドンの日本市場規模推移 ・ピルフェニドンの中国市場規模推移 ・ピルフェニドンの韓国市場規模推移 ・ピルフェニドンのインド市場規模推移 ・ピルフェニドンの東南アジア市場規模推移 ・ピルフェニドンの南米市場分析（ブラジル、アルゼンチン等） ・ピルフェニドンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ピルフェニドンの種類別分析/販売量、売上、市場シェア（タブレット、カプセル、その他） ・ピルフェニドンの用途別分析/市場規模（軽度特発性肺線維症、中等度特発性肺線維症、その他） ・ピルフェニドンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ピルフェニドンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Pirfenidone is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pirfenidone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablet
Capsule
Other
Market Segment by Applications, can be divided into
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pirfenidone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pirfenidone, with price, sales, revenue and global market share of Pirfenidone in 2017 and 2018.
Chapter 3, the Pirfenidone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pirfenidone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pirfenidone market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pirfenidone sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pirfenidone Introduction
1.2 Market Analysis by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Mild Idiopathic Pulmonary Fibrosis
1.3.2 Moderate Idiopathic Pulmonary Fibrosis
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genentech (Roche)
2.1.1 Business Overview
2.1.2 Pirfenidone Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genentech (Roche) Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shionogi
2.2.1 Business Overview
2.2.2 Pirfenidone Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shionogi Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GNI Group
2.3.1 Business Overview
2.3.2 Pirfenidone Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GNI Group Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Beijing Continent
2.4.1 Business Overview
2.4.2 Pirfenidone Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beijing Continent Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cipla
2.5.1 Business Overview
2.5.2 Pirfenidone Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cipla Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lupin Ltd
2.6.1 Business Overview
2.6.2 Pirfenidone Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Ltd Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Zydus Cadila
2.7.1 Business Overview
2.7.2 Pirfenidone Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Zydus Cadila Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Glenmark Pharmaceuticals
2.8.1 Business Overview
2.8.2 Pirfenidone Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Koye Pharmaceuticals
2.9.1 Business Overview
2.9.2 Pirfenidone Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Koye Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 MSN Laboratories
2.10.1 Business Overview
2.10.2 Pirfenidone Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 MSN Laboratories Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Pirfenidone Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Incepta Pharmaceuticals
2.12.1 Business Overview
2.12.2 Pirfenidone Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Unimed Unihealth
2.13.1 Business Overview
2.13.2 Pirfenidone Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Unimed Unihealth Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pirfenidone Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pirfenidone Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pirfenidone Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pirfenidone Manufacturer Market Share in 2018
3.3.2 Top 6 Pirfenidone Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pirfenidone Market Analysis by Regions
4.1 Global Pirfenidone Sales, Revenue and Market Share by Regions
4.1.1 Global Pirfenidone Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pirfenidone Revenue and Market Share by Regions (2014-2019)
4.2 North America Pirfenidone Sales and Growth Rate (2014-2019)
4.3 Europe Pirfenidone Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pirfenidone Sales and Growth Rate (2014-2019)
4.5 South America Pirfenidone Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pirfenidone Sales and Growth Rate (2014-2019)
5 North America Pirfenidone by Country
5.1 North America Pirfenidone Sales, Revenue and Market Share by Country
5.1.1 North America Pirfenidone Sales and Market Share by Country (2014-2019)
5.1.2 North America Pirfenidone Revenue and Market Share by Country (2014-2019)
5.2 United States Pirfenidone Sales and Growth Rate (2014-2019)
5.3 Canada Pirfenidone Sales and Growth Rate (2014-2019)
5.4 Mexico Pirfenidone Sales and Growth Rate (2014-2019)
6 Europe Pirfenidone by Country
6.1 Europe Pirfenidone Sales, Revenue and Market Share by Country
6.1.1 Europe Pirfenidone Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pirfenidone Revenue and Market Share by Country (2014-2019)
6.2 Germany Pirfenidone Sales and Growth Rate (2014-2019)
6.3 UK Pirfenidone Sales and Growth Rate (2014-2019)
6.4 France Pirfenidone Sales and Growth Rate (2014-2019)
6.5 Russia Pirfenidone Sales and Growth Rate (2014-2019)
6.6 Italy Pirfenidone Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pirfenidone by Country
7.1 Asia-Pacific Pirfenidone Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pirfenidone Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pirfenidone Revenue and Market Share by Country (2014-2019)
7.2 China Pirfenidone Sales and Growth Rate (2014-2019)
7.3 Japan Pirfenidone Sales and Growth Rate (2014-2019)
7.4 Korea Pirfenidone Sales and Growth Rate (2014-2019)
7.5 India Pirfenidone Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pirfenidone Sales and Growth Rate (2014-2019)
8 South America Pirfenidone by Country
8.1 South America Pirfenidone Sales, Revenue and Market Share by Country
8.1.1 South America Pirfenidone Sales and Market Share by Country (2014-2019)
8.1.2 South America Pirfenidone Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pirfenidone Sales and Growth Rate (2014-2019)
8.3 Argentina Pirfenidone Sales and Growth Rate (2014-2019)
8.4 Colombia Pirfenidone Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pirfenidone by Countries
9.1 Middle East and Africa Pirfenidone Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pirfenidone Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pirfenidone Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pirfenidone Sales and Growth Rate (2014-2019)
9.3 Turkey Pirfenidone Sales and Growth Rate (2014-2019)
9.4 Egypt Pirfenidone Sales and Growth Rate (2014-2019)
9.5 Nigeria Pirfenidone Sales and Growth Rate (2014-2019)
9.6 South Africa Pirfenidone Sales and Growth Rate (2014-2019)
10 Global Pirfenidone Market Segment by Type
10.1 Global Pirfenidone Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pirfenidone Sales and Market Share by Type (2014-2019)
10.1.2 Global Pirfenidone Revenue and Market Share by Type (2014-2019)
10.2 Tablet Sales Growth and Price
10.2.1 Global Tablet Sales Growth (2014-2019)
10.2.2 Global Tablet Price (2014-2019)
10.3 Capsule Sales Growth and Price
10.3.1 Global Capsule Sales Growth (2014-2019)
10.3.2 Global Capsule Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Pirfenidone Market Segment by Application
11.1 Global Pirfenidone Sales Market Share by Application (2014-2019)
11.2 Mild Idiopathic Pulmonary Fibrosis Sales Growth (2014-2019)
11.3 Moderate Idiopathic Pulmonary Fibrosis Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Pirfenidone Market Forecast (2019-2024)
12.1 Global Pirfenidone Sales, Revenue and Growth Rate (2019-2024)
12.2 Pirfenidone Market Forecast by Regions (2019-2024)
12.2.1 North America Pirfenidone Market Forecast (2019-2024)
12.2.2 Europe Pirfenidone Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pirfenidone Market Forecast (2019-2024)
12.2.4 South America Pirfenidone Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pirfenidone Market Forecast (2019-2024)
12.3 Pirfenidone Market Forecast by Type (2019-2024)
12.3.1 Global Pirfenidone Sales Forecast by Type (2019-2024)
12.3.2 Global Pirfenidone Market Share Forecast by Type (2019-2024)
12.4 Pirfenidone Market Forecast by Application (2019-2024)
12.4.1 Global Pirfenidone Sales Forecast by Application (2019-2024)
12.4.2 Global Pirfenidone Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Pirfenidone Picture
Table Product Specifications of Pirfenidone
Figure Global Sales Market Share of Pirfenidone by Types in 2018
Table Pirfenidone Types for Major Manufacturers
Figure Tablet Picture
Figure Capsule Picture
Figure Other Picture
Figure Pirfenidone Sales Market Share by Applications in 2018
Figure Mild Idiopathic Pulmonary Fibrosis Picture
Figure Moderate Idiopathic Pulmonary Fibrosis Picture
Figure Other Picture
Figure United States Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure France Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure UK Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure China Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure India Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Pirfenidone Revenue (Value) and Growth Rate (2014-2024)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Pirfenidone Type and Applications
Table Genentech (Roche) Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shionogi Basic Information, Manufacturing Base and Competitors
Table Shionogi Pirfenidone Type and Applications
Table Shionogi Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GNI Group Basic Information, Manufacturing Base and Competitors
Table GNI Group Pirfenidone Type and Applications
Table GNI Group Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Continent Basic Information, Manufacturing Base and Competitors
Table Beijing Continent Pirfenidone Type and Applications
Table Beijing Continent Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Pirfenidone Type and Applications
Table Cipla Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table Lupin Ltd Pirfenidone Type and Applications
Table Lupin Ltd Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table Zydus Cadila Pirfenidone Type and Applications
Table Zydus Cadila Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceuticals Pirfenidone Type and Applications
Table Glenmark Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Koye Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Koye Pharmaceuticals Pirfenidone Type and Applications
Table Koye Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table MSN Laboratories Pirfenidone Type and Applications
Table MSN Laboratories Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Pirfenidone Type and Applications
Table Wockhardt Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Incepta Pharmaceuticals Pirfenidone Type and Applications
Table Incepta Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Unimed Unihealth Basic Information, Manufacturing Base and Competitors
Table Unimed Unihealth Pirfenidone Type and Applications
Table Unimed Unihealth Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pirfenidone Sales by Manufacturer (2017-2018)
Figure Global Pirfenidone Sales Market Share by Manufacturer in 2017
Figure Global Pirfenidone Sales Market Share by Manufacturer in 2018
Table Global Pirfenidone Revenue by Manufacturer (2017-2018)
Figure Global Pirfenidone Revenue Market Share by Manufacturer in 2017
Figure Global Pirfenidone Revenue Market Share by Manufacturer in 2018
Figure Top 3 Pirfenidone Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Pirfenidone Manufacturer (Revenue) Market Share in 2018
Figure Global Pirfenidone Sales and Growth Rate (2014-2019)
Figure Global Pirfenidone Revenue and Growth Rate (2014-2019)
Table Global Pirfenidone Sales by Regions (2014-2019)
Table Global Pirfenidone Sales Market Share by Regions (2014-2019)
Table Global Pirfenidone Revenue by Regions (2014-2019)
Figure Global Pirfenidone Revenue Market Share by Regions (2014-2019)
Figure Global Pirfenidone Revenue Market Share by Regions in 2018
Figure North America Pirfenidone Sales and Growth Rate (2014-2019)
Figure Europe Pirfenidone Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pirfenidone Sales and Growth Rate (2014-2019)
Figure South America Pirfenidone Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pirfenidone Sales and Growth Rate (2014-2019)
Figure North America Pirfenidone Revenue and Growth Rate (2014-2019)
Table North America Pirfenidone Sales by Countries (2014-2019)
Table North America Pirfenidone Sales Market Share by Countries (2014-2019)
Figure North America Pirfenidone Sales Market Share by Countries (2014-2019)
Figure North America Pirfenidone Sales Market Share by Countries in 2018
Table North America Pirfenidone Revenue by Countries (2014-2019)
Table North America Pirfenidone Revenue Market Share by Countries (2014-2019)
Figure North America Pirfenidone Revenue Market Share by Countries (2014-2019)
Figure North America Pirfenidone Revenue Market Share by Countries in 2018
Figure United States Pirfenidone Sales and Growth Rate (2014-2019)
Figure Canada Pirfenidone Sales and Growth Rate (2014-2019)
Figure Mexico Pirfenidone Sales and Growth Rate (2014-2019)
Figure Europe Pirfenidone Revenue and Growth Rate (2014-2019)
Table Europe Pirfenidone Sales by Countries (2014-2019)
Table Europe Pirfenidone Sales Market Share by Countries (2014-2019)
Table Europe Pirfenidone Revenue by Countries (2014-2019)
Figure Europe Pirfenidone Revenue Market Share by Countries (2014-2019)
Figure Europe Pirfenidone Revenue Market Share by Countries in 2018
Figure Germany Pirfenidone Sales and Growth Rate (2014-2019)
Figure UK Pirfenidone Sales and Growth Rate (2014-2019)
Figure France Pirfenidone Sales and Growth Rate (2014-2019)
Figure Russia Pirfenidone Sales and Growth Rate (2014-2019)
Figure Italy Pirfenidone Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pirfenidone Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pirfenidone Sales by Countries (2014-2019)
Table Asia-Pacific Pirfenidone Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Pirfenidone Sales Market Share by Countries 2018
Table Asia-Pacific Pirfenidone Revenue by Countries (2014-2019)
Figure Asia-Pacific Pirfenidone Revenue Market Share by Countries 2018
Figure China Pirfenidone Sales and Growth Rate (2014-2019)
Figure Japan Pirfenidone Sales and Growth Rate (2014-2019)
Figure Korea Pirfenidone Sales and Growth Rate (2014-2019)
Figure India Pirfenidone Sales and Growth Rate (2014-2019)
Figure Southeast Asia Pirfenidone Sales and Growth Rate (2014-2019)
Figure South America Pirfenidone Revenue and Growth Rate (2014-2019)
Table South America Pirfenidone Sales by Countries (2014-2019)
Table South America Pirfenidone Sales Market Share by Countries (2014-2019)
Figure South America Pirfenidone Sales Market Share by Countries in 2018
Table South America Pirfenidone Revenue by Countries (2014-2019)
Table South America Pirfenidone Revenue Market Share by Countries (2014-2019)
Figure South America Pirfenidone Revenue Market Share by Countries in 2018
Figure Brazil Pirfenidone Sales and Growth Rate (2014-2019)
Figure Argentina Pirfenidone Sales and Growth Rate (2014-2019)
Figure Colombia Pirfenidone Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pirfenidone Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pirfenidone Sales by Countries (2014-2019)
Table Middle East and Africa Pirfenidone Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Pirfenidone Sales Market Share by Countries in 2018
Table Middle East and Africa Pirfenidone Revenue by Countries (2014-2019)
Table Middle East and Africa Pirfenidone Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pirfenidone Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pirfenidone Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pirfenidone Sales and Growth Rate (2014-2019)
Figure UAE Pirfenidone Sales and Growth Rate (2014-2019)
Figure Egypt Pirfenidone Sales and Growth Rate (2014-2019)
Figure Nigeria Pirfenidone Sales and Growth Rate (2014-2019)
Figure South Africa Pirfenidone Sales and Growth Rate (2014-2019)
Table Global Pirfenidone Sales by Type (2014-2019)
Table Global Pirfenidone Sales Share by Type (2014-2019)
Table Global Pirfenidone Revenue by Type (2014-2019)
Table Global Pirfenidone Revenue Share by Type (2014-2019)
Figure Global Tablet Sales Growth (2014-2019)
Figure Global Tablet Price (2014-2019)
Figure Global Capsule Sales Growth (2014-2019)
Figure Global Capsule Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Pirfenidone Sales by Application (2014-2019)
Table Global Pirfenidone Sales Share by Application (2014-2019)
Figure Global Moderate Idiopathic Pulmonary Fibrosis Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Pirfenidone Sales, Revenue and Growth Rate (2019-2024)
Table Global Pirfenidone Sales Forecast by Regions (2019-2024)
Table Global Pirfenidone Market Share Forecast by Regions (2019-2024)
Figure North America Sales Pirfenidone Market Forecast (2019-2024)
Figure Europe Sales Pirfenidone Market Forecast (2019-2024)
Figure Asia-Pacific Sales Pirfenidone Market Forecast (2019-2024)
Figure South America Sales Pirfenidone Market Forecast (2019-2024)
Figure Middle East and Africa Sales Pirfenidone Market Forecast (2019-2024)
Table Global Pirfenidone Sales Forecast by Type (2019-2024)
Table Global Pirfenidone Market Share Forecast by Type (2019-2024)
Table Global Pirfenidone Sales Forecast by Application (2019-2024)
Table Global Pirfenidone Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
肝線維症治療薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen. Scope of the Report: The classi…- 慢性特発性骨髄線維症市場：世界及び中国市場分析・予測（～2024年） Chronic Idiopathic Myelofibrosis Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Chronic Idiopathic Myelofibrosis industry with a focus on the Chinese market. The report provides key statistics on the market status of the Chro…
- 特発性血小板減少性紫斑病（LTP)治療薬市場：世界及び中国市場分析・予測（～2024年） Idiopathic Thrombocytopenic Purpura Itp Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Idiopathic Thrombocytopenic Purpura Itp Therapeutics industry with a focus on the Chinese market. The report provides key sta…
- 世界の軽度から中等度のアトピー性皮膚炎の治療市場：市場規模・現状・予測 Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood.Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors. North Ameri…
- 経カテーテル肺動脈弁（TPV）の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Transcatheter Pulmonary Valve (TPV) is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Transcatheter…